Outcomes of AIDS-associated Kaposi sarcoma in Mozambique after treatment with pegylated liposomal doxorubicin
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-9378
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Outcomes of AIDS-associated Kaposi sarcoma in Mozambique after treatment with pegylated liposomal doxorubicin ; volume:16 ; number:1 ; day:7 ; month:1 ; year:2021 ; pages:1-11 ; date:12.2021
Infectious agents and cancer ; 16, Heft 1 (7.1.2021), 1-11, 12.2021
- Creator
-
Coldiron, Matthew E.
Gutierrez Zamudio, Ana Gabriela
Manuel, Rolanda
Luciano, Gilda
Rusch, Barbara
Ciglenecki, Iza
Telnov, Alex
Grais, Rebecca F.
Trellu, Laurence Toutous
Molfino, Lucas
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13027-020-00341-4
- URN
-
urn:nbn:de:101:1-2021020805293120885589
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Coldiron, Matthew E.
- Gutierrez Zamudio, Ana Gabriela
- Manuel, Rolanda
- Luciano, Gilda
- Rusch, Barbara
- Ciglenecki, Iza
- Telnov, Alex
- Grais, Rebecca F.
- Trellu, Laurence Toutous
- Molfino, Lucas
- SpringerLink (Online service)
Other Objects (12)
Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
Pegylated and liposomal doxorubicin is associated with high mortality and causes limited cardiotoxicity in mice
A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?
Histological evidence for the cardiac safety of high-dose pegylated liposomal doxorubicin in a patient with HIV-associated Kaposi sarcoma: a case report and literature review
LRP1B Expression as a Putative Predictor of Response to Pegylated Liposomal Doxorubicin Treatment in Ovarian Cancer
Kinetic Targeting of pegylated liposomal Doxorubicin: a new Approach to Reduce Toxicity during Chemotherapy (CARL-trial)
Behandlung des Kaposi Sarkoms bei AIDS mit liposomal verkapseltem Doxorubicin : Ergebnisse einer Phase I-II Studie
Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
Pegylated and liposomal doxorubicin is associated with high mortality and causes limited cardiotoxicity in mice
A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?
Histological evidence for the cardiac safety of high-dose pegylated liposomal doxorubicin in a patient with HIV-associated Kaposi sarcoma: a case report and literature review
LRP1B Expression as a Putative Predictor of Response to Pegylated Liposomal Doxorubicin Treatment in Ovarian Cancer
Kinetic Targeting of pegylated liposomal Doxorubicin: a new Approach to Reduce Toxicity during Chemotherapy (CARL-trial)
Behandlung des Kaposi Sarkoms bei AIDS mit liposomal verkapseltem Doxorubicin : Ergebnisse einer Phase I-II Studie
Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
Pegylated and liposomal doxorubicin is associated with high mortality and causes limited cardiotoxicity in mice
A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?
Histological evidence for the cardiac safety of high-dose pegylated liposomal doxorubicin in a patient with HIV-associated Kaposi sarcoma: a case report and literature review
LRP1B Expression as a Putative Predictor of Response to Pegylated Liposomal Doxorubicin Treatment in Ovarian Cancer
Kinetic Targeting of pegylated liposomal Doxorubicin: a new Approach to Reduce Toxicity during Chemotherapy (CARL-trial)